These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3561065)

  • 1. [Post-chemotherapy hypothermia in non-Hodgkin's lymphoma].
    Guedea F; Domingo P; Ris J
    Med Clin (Barc); 1987 Feb; 88(6):257. PubMed ID: 3561065
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy-induced hypothermia in non-Hodgkin's lymphoma.
    Manoharan A; Lewis CR
    Cancer Treat Rep; 1986 Nov; 70(11):1347. PubMed ID: 3768881
    [No Abstract]   [Full Text] [Related]  

  • 3. Essential thrombocythemia after treatment of non-Hodgkin's lymphoma.
    Maciel JF; de Lourdes Chauffaille M; Inaoka RJ; Colleoni GW; Yamamoto M
    Leuk Res; 2007 Nov; 31(11):1593-5. PubMed ID: 17324461
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acute gouty arthritis and non-Hodgkin's lymphoma].
    Calvo Villas JM; Cuesta Tovar J; Sicilia Guillén FJ
    An Med Interna; 2003 Feb; 20(2):107-8. PubMed ID: 12703171
    [No Abstract]   [Full Text] [Related]  

  • 5. Prednisone, oral etoposide, and novantrone for treatment of non-Hodgkin's lymphoma: a preliminary report.
    Goss PE; Burkes R; Rudinskas L; King M; Chow W; Myers R; Davidson M; Poldre P; Crump M; Sutton D
    Semin Hematol; 1994 Apr; 31(2 Suppl 3):23-9. PubMed ID: 8073303
    [No Abstract]   [Full Text] [Related]  

  • 6. [Low grade non-Hodgkin's lymphoma after combined therapy for Hodgkin's disease].
    Raya Sánchez JM; González Brito G; Hernández Nieto L; Brito Barroso ML; Alvarez Argüelles H; Jorge Hernández JA; Martín Herrera A
    Sangre (Barc); 1994 Dec; 39(6):461-4. PubMed ID: 7855699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytarabine, cisplatin, and etoposide chemotherapy for refractory non-Hodgkin's lymphoma.
    O'Donnell MR; Forman SJ; Levine AM; Territo M; Farbstein MJ; Fahey JL; Gill P; Lazar G; Nademanee A; Neely S
    Cancer Treat Rep; 1987 Feb; 71(2):187-9. PubMed ID: 3802114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypothermia during chemotherapy for lymphomas].
    Gabryś K; Mazur G
    Pol Arch Med Wewn; 1995 Feb; 93(2):130-4. PubMed ID: 7479230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage chemotherapy for non-Hodgkin's lymphoma with a combination of mitoxantrone, etoposide, cisplatin, and prednisolone.
    Ohnoshi T; Hayashi K; Ueoka H; Yamane T; Ueno K; Murashima M; Tada A; Yoshida M; Kimura I
    Cancer Treat Rep; 1987 Jun; 71(6):639-41. PubMed ID: 3581103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothermia following chemotherapy for Hodgkin's disease.
    Weens JH; Hernandez B
    Cancer Treat Rep; 1986 Feb; 70(2):313-4. PubMed ID: 3948197
    [No Abstract]   [Full Text] [Related]  

  • 11. ESHAP chemotherapy for relapsed/refractory non-Hodgkin's lymphoma.
    Sweetenham JW; Johnson PW
    J Clin Oncol; 1994 Dec; 12(12):2766. PubMed ID: 7989954
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of front-line chemotherapy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens. The Nebraska Lymphoma Study Group.
    Vose JM; Anderson JR; Bierman PJ; Bast M; Weisenburger D; Chan WC; Bishop MR; Armitage JO
    Semin Hematol; 1994 Apr; 31(2 Suppl 3):4-8. PubMed ID: 7521065
    [No Abstract]   [Full Text] [Related]  

  • 13. Nursing care of the patient with non-Hodgkin's lymphoma: prevention of pneumonia associated with combination chemotherapy.
    Foote M
    Cancer Nurs; 1985 Oct; 8(5):263-71. PubMed ID: 3854962
    [No Abstract]   [Full Text] [Related]  

  • 14. Mitoxantrone in combination with etoposide and prednimustine in patients older than 70 years with unfavorable non-Hodgkin's lymphoma: a prospective study in 52 patients.
    Tirelli U; Zagonel V; Sorio R; Errante D; Talamini R; Carbone A; Monfardini S
    Semin Hematol; 1994 Apr; 31(2 Suppl 3):13-22. PubMed ID: 8073302
    [No Abstract]   [Full Text] [Related]  

  • 15. A progressive parkinsonian syndrome developing after chemotherapy and radiotherapy for non-Hodgkin's lymphoma.
    Howell SJ; Sagar HJ
    Mov Disord; 1994 May; 9(3):373-5. PubMed ID: 8041386
    [No Abstract]   [Full Text] [Related]  

  • 16. Full-dose chemotherapy for non-Hodgkin's lymphoma in the elderly. Dutch Hematology-Oncology in Adults Study Group.
    Sonneveld P; Hop W; Mulder AH; Michiels JJ; Blijham G; van de Lelie J; Raemakers JW; Nieuwenhuis K; van der Heul C
    Semin Hematol; 1994 Apr; 31(2 Suppl 3):9-12. PubMed ID: 8073309
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of primary rectal non-Hodgkin's lymphoma treated with chemotherapy.
    Singla R; Kumar P; Bahl A; Kumar S; Saran RK; Kar P
    Trop Gastroenterol; 2008; 29(4):227-8. PubMed ID: 19323094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of refractory non-Hodgkin's lymphomas of unfavorable histology with teniposide, cytarabine, and cisplatin.
    Tseng A; Jacobs C; Coleman CN; Horning SJ; Lewis BJ; Rosenberg SA
    Cancer Treat Rep; 1987 Jun; 71(6):659-60. PubMed ID: 3581106
    [No Abstract]   [Full Text] [Related]  

  • 19. Etoposide and mitoguazone in refractory or recurrent non-Hodgkin's lymphomas of the unfavorable histologic subtypes.
    Winter JN; Gordon LI; Hauck WW; Variakojis D
    Cancer Treat Rep; 1986 Oct; 70(10):1243-4. PubMed ID: 3756945
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma.
    Klumpp TR; Mangan KF; Glenn LD; Malaspina DR; Cropper T; Mullaney M; Macdonald JS
    Bone Marrow Transplant; 1993 Oct; 12(4):337-45. PubMed ID: 7506091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.